MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.41 -0.06 (-0.52%)
At close: Oct 2, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Net Preferred Shares Issued and Repurchased (2021)

Updated

MoonLake Immunotherapeutics (MLTX) recorded Net Preferred Shares Issued and Repurchased of $4,894 in Q4 2021, down 99.0% from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Net Preferred Shares Issued and Repurchased (2021) Analysis & Trends

For FY2021, MoonLake Immunotherapeutics reported Net Preferred Shares Issued and Repurchased of $28.16 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 MoonLake Immunotherapeutics 971.07 Mn -698.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 4,894.00
Sep 30, 2021 495,050.00
API Access

MoonLake Immunotherapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=MLTX&period=max&api_key=YOUR_API_KEY